Merck-Harpoon US antitrust waiting period expired
MLex Summary: Merck's acquisition of Harpoon Therapeutics had its US antitrust waiting period expire yesterday, according to a securities disclosure from Harpoon.See excerpt below:...To view the full article, register now.
Already a subscriber? Click here to view full article